Author response for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"
Year: 2019
Type: peer-review
Source: Publons reviews and discussion
Authors: Yuan‐Di Halvorsen, Geoffrey A Walford, Joseph Massaro, R. Paul Aftring, Mason W. Freeman
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4249121431